TWD 51.7
(-4.44%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 389.62 Million TWD | 6.73% |
2022 | 365.04 Million TWD | -88.87% |
2021 | 3.28 Billion TWD | 28413.03% |
2020 | 11.5 Million TWD | 927.41% |
2019 | 1.12 Million TWD | 0.0% |
2018 | - TWD | 0.0% |
2017 | - TWD | 0.0% |
2016 | - TWD | 0.0% |
2015 | - TWD | 0.0% |
2014 | - TWD | 0.0% |
2013 | - TWD | 0.0% |
2012 | - TWD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 175.22 Million TWD | 199.02% |
2024 Q1 | 58.6 Million TWD | -65.8% |
2024 Q3 | 243 Million TWD | 38.68% |
2023 Q4 | 171.33 Million TWD | -21.51% |
2023 Q1 | - TWD | -100.0% |
2023 Q3 | 218.28 Million TWD | 0.0% |
2023 Q2 | - TWD | 0.0% |
2023 FY | 389.62 Million TWD | 6.73% |
2022 Q4 | 23.73 Million TWD | 1033.29% |
2022 Q2 | 12.58 Million TWD | -96.15% |
2022 Q1 | 326.63 Million TWD | -83.91% |
2022 FY | 365.04 Million TWD | -88.87% |
2022 Q3 | 2.09 Million TWD | -83.36% |
2021 Q2 | 933 Thousand TWD | -70.31% |
2021 Q4 | 2.03 Billion TWD | 62.81% |
2021 Q1 | 3.14 Million TWD | -54.63% |
2021 FY | 3.28 Billion TWD | 28413.03% |
2021 Q3 | 1.24 Billion TWD | 133543.94% |
2020 Q3 | 2.94 Million TWD | 156.21% |
2020 FY | 11.5 Million TWD | 927.41% |
2020 Q2 | 1.15 Million TWD | 139.79% |
2020 Q1 | 480 Thousand TWD | 0.0% |
2020 Q4 | 6.92 Million TWD | 134.89% |
2019 Q3 | - TWD | -100.0% |
2019 FY | 1.12 Million TWD | 0.0% |
2019 Q4 | 480 Thousand TWD | 0.0% |
2019 Q2 | 640 Thousand TWD | 0.0% |
2019 Q1 | - TWD | 0.0% |
2018 Q4 | - TWD | 0.0% |
2018 FY | - TWD | 0.0% |
2018 Q2 | - TWD | 0.0% |
2018 Q1 | - TWD | 0.0% |
2018 Q3 | - TWD | 0.0% |
2017 FY | - TWD | 0.0% |
2017 Q4 | - TWD | 0.0% |
2017 Q2 | - TWD | 0.0% |
2017 Q3 | - TWD | 0.0% |
2017 Q1 | - TWD | 0.0% |
2016 Q4 | - TWD | 0.0% |
2016 Q3 | - TWD | 0.0% |
2016 Q1 | - TWD | 0.0% |
2016 Q2 | - TWD | 0.0% |
2016 FY | - TWD | 0.0% |
2015 Q3 | - TWD | 0.0% |
2015 Q1 | - TWD | 0.0% |
2015 Q2 | - TWD | 0.0% |
2015 FY | - TWD | 0.0% |
2015 Q4 | - TWD | 0.0% |
2014 FY | - TWD | 0.0% |
2014 Q4 | - TWD | 0.0% |
2014 Q3 | - TWD | 0.0% |
2014 Q2 | - TWD | 0.0% |
2014 Q1 | - TWD | 0.0% |
2013 FY | - TWD | 0.0% |
2012 FY | - TWD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 1.11 Billion TWD | 65.046% |
Level Biotechnology Inc. | 660.61 Million TWD | 41.021% |
TaiMed Biologics Inc. | 491.77 Million TWD | 20.772% |
GlycoNex Incorporation | 2.54 Million TWD | -15227.459% |
GeneReach Biotechnology Corp. | 225.46 Million TWD | -72.813% |
OBI Pharma, Inc. | 41.54 Million TWD | -837.746% |
Taiwan Advance Bio-Pharmaceutical Inc. | 315.98 Million TWD | -23.305% |
Genomics BioSci & Tech. Co.,Ltd. | 396.14 Million TWD | 1.645% |
Visgeneer Inc. | 147.99 Million TWD | -163.27% |
Neith Corporation | 39.9 Million TWD | -876.428% |
Lumosa Therapeutics Co., Ltd. | 56.91 Million TWD | -584.56% |
TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | -1613.235% |
Enimmune corporation | 43.49 Million TWD | -795.811% |
TaiRx, Inc. | 5.08 Million TWD | -7566.745% |
CHO Pharma, Inc. | - TWD | -Infinity% |
BioLASCO Taiwan Co., Ltd. | 264.72 Million TWD | -47.182% |
Sunny Pharmtech Inc. | 428.82 Million TWD | 9.142% |
Ever Supreme Bio Technology Co., Ltd | 758.39 Million TWD | 48.625% |
Feng Chi Biotech Corp. | 180.57 Million TWD | -115.765% |
Lukas Biomedical Inc. | 231.83 Million TWD | -68.062% |
RBC Bioscience Corporation | 172.46 Million TWD | -125.912% |
NaviFUS Corp. | 22.48 Million TWD | -1633.126% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -432815.556% |
Shine-On BioMedical Co.,Ltd. | 9.52 Million TWD | -3990.97% |
Great Novel Therapeutics Biotech & Medicals | 4.85 Million TWD | -7933.485% |
Sagittarius Life Science Corp | 440.46 Million TWD | 11.542% |
Bio Preventive Medicine Corp. | 1.2 Million TWD | -32153.642% |
Advagene Biopharma Co., Ltd. | - TWD | -Infinity% |
BioGend Therapeutics Co., Ltd. | 109.9 Million TWD | -254.5% |
G&E Herbal Biotechnology Co., Ltd. | 181.44 Million TWD | -114.736% |
Andros Pharmaceuticals Co.,Ltd | 805 Thousand TWD | -48300.497% |
Lin BioScience, Inc. | - TWD | -Infinity% |
Anti-Microbial Savior BioteQ Co., Ltd | 728 Thousand TWD | -53419.78% |
AP Biosciences Inc | 32.25 Million TWD | -1108.024% |
Sunmax Biotechnology Co., Ltd. | 1.68 Billion TWD | 76.931% |
Syngen Biotech Co.,Ltd. | 1.83 Billion TWD | 78.792% |
EirGenix Inc. | 1.02 Billion TWD | 61.901% |
Pharmosa Biopharm Inc. | 314.5 Million TWD | -23.887% |
Mycenax Biotech Inc. | 652.62 Million TWD | 40.298% |
SynCore Biotechnology Co.,Ltd | 20.19 Million TWD | -1829.214% |
Eusol Biotech Co.,Ltd. | - TWD | -Infinity% |
NeoCore Technology Co., Ltd. | 64.72 Million TWD | -501.931% |
VBI | 55.85 Million TWD | -597.588% |
BiOptic Inc. | 228.26 Million TWD | -70.686% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 141.17 Million TWD | -175.985% |
Sinew Pharma Inc. | - TWD | -Infinity% |
Greenyn Biotechnology Co., Ltd | 800.51 Million TWD | 51.328% |
Medigen Biotechnology Corp. | 1.15 Billion TWD | 66.346% |
3D Global Biotech Inc. | 20.63 Million TWD | -1788.354% |
Intech Biopharm Corporation | 25.84 Million TWD | -1407.424% |
Oneness Biotech Co., Ltd. | 86.78 Million TWD | -348.964% |
TWi Biotechnology, Inc. | - TWD | -Infinity% |
TCI GENE Inc. | 333.85 Million TWD | -16.705% |
MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -2164477.778% |
Senhwa Biosciences, Inc. | 1 Million TWD | -38862.4% |
Taiwan Bio Therapeutics Co., Ltd | 85.47 Million TWD | -355.861% |
NatureWise Biotech & Medicals Corporation | 160.14 Million TWD | -143.299% |
PharmaEngine, Inc. | 767.66 Million TWD | 49.246% |
Savior Lifetec Corporation | 1.05 Billion TWD | 62.903% |
TaiGen Biopharmaceuticals Holdings Limited | 123.13 Million TWD | -216.423% |
Meribank Biotech Co., Ltd | 234.34 Million TWD | -66.263% |
Acepodia, Inc. | 16.59 Million TWD | -2248.123% |
Caliway Biopharmaceuticals Co., Ltd. | 38.93 Million TWD | -900.781% |